Carle Health System Regional Seminar on Diabetes 2025

Advanced Diabetes, Cardiometabolic Health & Metabolic Disease Management Update

The Carle Health System Regional Seminar on Diabetes 2025 provides a focused, evidence-based review of contemporary diabetes care, cardiometabolic medicine, and metabolic disease management. This educational program highlights the latest advances in diabetes technology, cardiovascular risk reduction, renal protection, obesity treatment, and the management of metabolic dysfunction-associated steatotic liver disease (MASLD).

Designed for endocrinologists, primary care physicians, internists, advanced practice providers, and clinicians involved in diabetes care, the seminar emphasizes practical strategies that improve glycemic control, reduce cardiovascular complications, and optimize long-term patient outcomes.

Product Details

• Course Date: October 17, 2025
• Format: 1 Video + 1 PDF
• Size: 2.02 GB
• Access: On-Demand

Program Overview

Diabetes management continues to evolve rapidly with advances in continuous glucose monitoring, cardioprotective therapies, weight management medications, and integrated approaches to metabolic health. Modern diabetes care now extends beyond glucose control to encompass cardiovascular disease prevention, kidney protection, obesity treatment, and management of associated metabolic disorders.

The Carle Health System Regional Seminar on Diabetes 2025 delivers practical updates on:

• Type 2 diabetes management
• Continuous glucose monitoring (CGM)
• SGLT2 inhibitors
• GLP-1 receptor agonists
• Cardiovascular disease prevention
• Chronic kidney disease in diabetes
• Metabolic dysfunction-associated steatotic liver disease (MASLD)
• Insulin therapy advances
• Obesity and metabolic health
• Comprehensive cardiometabolic care

The curriculum is designed to help clinicians integrate current evidence and guideline-based therapies into daily clinical practice.

Learning Objectives

Upon completion of this activity, participants will be able to:

• Evaluate the cardiovascular and renal benefits of SGLT2 inhibitors and GLP-1 receptor agonists.
• Utilize continuous glucose monitoring systems to improve diabetes management.
• Develop comprehensive treatment strategies for patients with cardiometabolic disease.
• Recognize and manage metabolic dysfunction-associated steatotic liver disease (MASLD).
• Incorporate updated insulin therapies into individualized treatment plans.
• Apply evidence-based approaches to reduce cardiovascular risk in diabetic patients.
• Integrate diabetes technology into routine patient care.
• Improve long-term outcomes through multidisciplinary cardiometabolic management.

Continuous Glucose Monitoring (CGM)

A major focus of the seminar is the expanding role of diabetes technology in modern patient care.

Topics include:

• Continuous glucose monitoring systems
• CGM interpretation
• Time-in-range optimization
• Glucose pattern recognition
• Clinical decision-making using CGM data
• Patient education strategies
• Technology integration into primary care

Participants learn practical approaches for improving glycemic outcomes through advanced monitoring technologies.

SGLT2 Inhibitors & GLP-1 Receptor Agonists

The course reviews the rapidly expanding evidence supporting targeted diabetes therapies.

Topics include:

• SGLT2 inhibitor therapy
• GLP-1 receptor agonists
• Cardiovascular protection
• Renal risk reduction
• Weight management benefits
• Patient selection strategies
• Safety and monitoring considerations

Faculty discuss how these medications have transformed diabetes and cardiometabolic care.

Cardiovascular Disease & Diabetes

Cardiovascular disease remains the leading cause of morbidity and mortality among patients with diabetes.

Sessions review:

• Atherosclerotic cardiovascular disease prevention
• Heart failure management
• Cardiometabolic risk reduction
• Lipid management strategies
• Blood pressure control
• Integrated cardiovascular care

Participants gain practical guidance on reducing cardiovascular complications in diabetic populations.

Kidney Disease & Metabolic Health

The seminar explores modern approaches to preserving renal function in patients with diabetes.

Topics include:

• Chronic kidney disease screening
• Renal protective therapies
• SGLT2 inhibitor kidney benefits
• Risk stratification
• Monitoring renal outcomes
• Comprehensive kidney care strategies

Faculty emphasize early intervention and evidence-based management approaches.

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

As MASLD becomes increasingly prevalent among patients with diabetes and obesity, clinicians must be prepared to recognize and manage this condition.

Topics include:

• MASLD diagnosis
• Risk assessment
• Liver disease progression
• Metabolic risk factors
• Weight loss interventions
• Pharmacologic management strategies

Participants learn practical approaches to integrating liver health into comprehensive metabolic care.

Advances in Insulin Therapy

The program also reviews current developments in insulin treatment.

Topics include:

• Modern basal insulin therapies
• Insulin intensification strategies
• Individualized insulin management
• Hypoglycemia prevention
• Combination therapy approaches
• Patient adherence optimization

Faculty provide practical recommendations for improving glycemic control while minimizing treatment burden.

Comprehensive Cardiometabolic Care

The seminar emphasizes a holistic approach to managing diabetes and its associated complications.

Topics include:

• Obesity management
• Lifestyle interventions
• Exercise and cardiac rehabilitation
• Nutrition strategies
• Cardiovascular risk reduction
• Multidisciplinary care models

Participants gain tools to address the full spectrum of metabolic disease.

Target Audience

This course is ideal for:

• Endocrinologists
• Primary Care Physicians
• Internal Medicine Physicians
• Family Medicine Physicians
• Diabetologists
• Cardiologists
• Nephrologists
• Nurse Practitioners
• Physician Assistants
• Diabetes Educators

    Topics

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

• Friday, October 17, 2025.mp4 Full Live

*Detail:

• 8:00 a.m. – 8:15 a.m. Opening Remarks Kingsley Onyemere, MD, MPH, FACP Endocrinology Carle Health
• 8:15 a.m. – 9:00 a.m. Cardiovascular Benefits of SGLT2-Inhibitors and GLP-1 Agonists Karen Wiarda, DO Carle Heart and Vascular Institute
• 9:00 a.m. – 10:00 a.m. Using Continuous Glucose Monitoring to Advance Cardiometabolic Kidney Care Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP Midwestern University College of Pharmacy Clinical Pharmacist, Northwestern Medicine
• 10:00 a.m. – 10:15 a.m. Break and Exhibit Hall
• 10:15 a.m. – 11:15 a.m. Diabetes Technology Update Kelcey Semple, PharmD, BCACP, BCADM Carle Health
• 11:15 a.m. – 12:15 p.m. Diabetes and Heart Disease Cardiac Rehab and Exercising with Diabetes Kristina Adams-Smith, MS, RD, LDN Joseph Mulconrey, BS
• 12:15 p.m. – 1:00 p.m. Lunch and Exhibit Hall
• 1:00 p.m. – 2:00 p.m. Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Diabetes: Unraveling the Silent Foe Adeyinka Taiwo, MD Endocrinologist Clinical Assistant Professor University of Iowa
• 2:00 p.m. – 3:00 p.m. Insulin Marc Belanger, PharmD Carle Health
• 3:00 p.m. – 3:15 p.m. Break and Exhibit Hall
• 3:15 p.m. – 4:15 p.m. Endocrinology Panel Owaise Mansuri, MD Abbie Morales, RN, BSN, AMB-BC Coral Zahnd, CMA Holly Miller, MBA, RD, LDN, CDCES
• 4:15 p.m. – 4:30 p.m. Closing Remarks Jean Land, MS, RDN, LDN, CDCES Diabetes Program Coordinator Carle Health